HERMES PHARMA
  • SearchMobile only
  • ContactMobile only
  • Why HERMES PHARMA
    • Full-service provider
      • Project management
      • Research & development
      • Formulation development
      • Analytical services
      • Clinical studies
      • Regulatory services
      • Sourcing
      • Manufacturing
      • Quality management
      • Logistics & order management
    • Quality-first approach
      • Our QbD/PAT-driven processes
      • Specialist manufacturing facilities
    • Sustainability & ESG
      • Our commitment to sustainability
    • History
    • Executive team
  • Dosage forms & drug delivery
    • Swallowing difficulties
    • User-friendly dosage forms
      • Orally disintegrating granules
      • Chewable tablets
      • Effervescent tablets
      • Instant drinks
      • Lozenges
    • Your route to new products
  • Innovation
    center
    • Featured products
      • Magnesium
      • Macrogol
    • Pioneering technologies
      • Flavoring
      • Taste masking technologies
      • Granulation technologies
      • Serialization
    • User-friendly packaging
      • Innovative packaging options
  • News & media center
    • News & media center
    • Memberships
  • Jobs & careers

Contact

EN DE

Your Search

Reset
  • All results
  • Pages
  • Articles in the press
  • Brochures
  • Company news
  • Educational resources
  • News
  • Podcasts
  • Press releases
  • Videos
  • Events
86 Results
  • Articles in the press

    Making a Difference – Quality by Design (QbD)

    With pharma often reluctant to make use of innovation when it comes to manufacturing, it is necessary to implement regulatory policies to encourage industry-wide adoption of novel technology. Using a Quality by Design approach can provide an answer, resulting in lower costs and shorter project …

  • Articles in the press

    The problem with Pills – Why conventional dosage forms don’t meet modern consumer needs

    Millions of people around the world take tablets and capsules every day, but recent data suggests that a substantial proportion find these dosage forms difficult to swallow and inconvenient to take. What is it about tablets and capsules that cause some people to abstain from …

  • Articles in the press

    Innovative Excipients in Solid-Dosage Manufacturing

    Oral formulations, which form the largest category of pharmaceutical dosage forms, tend to require more excipients than other preparations. As a result, trends in oral solid dosage forms have a significant impact on excipient demand. The article looks at key considerations in selecting excipients during …

  • News, Company news

    HERMES PHARMA Receives Recognition for Research Excellence from German Government

    HERMES PHARMA, the leading expert in user-friendly oral dosage forms, has been awarded the BSFZ seal from the German Certification Office for Research AllowanceThis recognition underscores the company’s significant contributions to pharmaceutical manufacturing innovation and its commitment to advancing healthcare solutions that benefit both …

  • Articles in the press

    Effervescent Evolution: New Technologies and Method Revitalize a Time-Tested Dosage Form

    HERMES PHARMA’s new patent optimizes effervescent tablet manufacture, addressing consumer demand for ease of swallowing, choice and convenience.The pharmaceutical industry faces a significant challenge: over 50% of people struggle to swallow conventional tablets and capsules. This difficulty, combined with shifting consumer and patient preferences towards …

  • Articles in the press

    Safety Meets Accessibility: Creating the Ideal Packaging for On-The-Go Dosage Forms

    HERMES PHARMA develops user-friendly stick pack that safeguards children while ensuring easy access for adultsPatient-centric innovation is transforming pharmaceutical packaging, focusing on meeting diverse user needs while upholding the highest safety standards. Today’s consumers and patients demand medications that integrate seamlessly into daily life, driving …

Previous Page
1 … 7 8 9
HERMES PHARMA

Privacy policy

Cookie settings

Whistleblowing system

Imprint

Terms of use

Terms & conditions

Sitemap

LinkedIn

Youtube

Code of conduct

Contact
Search
LinkedIn